We are live on ! Find out more
CIC

Cornercap Investment Counsel Portfolio holdings

AUM $203M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$649M
AUM Growth
+$38.4M
Cap. Flow
+$1.52M
Cap. Flow %
0.23%
Top 10 Hldgs %
8.38%
Holding
684
New
103
Increased
174
Reduced
151
Closed
77

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$2.43M
2
LMT icon
Lockheed Martin
LMT
+$2.07M
3
WFC icon
Wells Fargo
WFC
+$2.06M
4
SPGI icon
S&P Global
SPGI
+$2.04M
5
TFC icon
Truist Financial
TFC
+$1.8M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$2.6M
2
PH icon
Parker-Hannifin
PH
+$2.49M
3
AVGO icon
Broadcom
AVGO
+$2.4M
4
AXP icon
American Express
AXP
+$2.36M
5
CB icon
Chubb
CB
+$2.07M

Sector Composition

Rank Sector Weight
1 Financials 18.76%
2 Technology 17.7%
3 Healthcare 14.05%
4 Industrials 12.92%
5 Consumer Discretionary 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTU icon
501
Intuit
INTU
$91.5B
$380K 0.06%
584
-1
-0.2% -$638
SAM icon
502
Boston Beer
SAM
$1.86B
$378K 0.06%
1,241
LXP icon
503
LXP Industrial Trust
LXP
$3.58B
$366K 0.06%
8,114
SBDS
504
DELISTED
Solo Brands Inc
SBDS
$354K 0.05%
4,073
+1,645
+68% +$189K
WVE icon
505
Wave Life Sciences
WVE
$1.2B
$346K 0.05%
+56,051
New +$281K
APH icon
506
Amphenol
APH
$207B
$343K 0.05%
5,940
TNYA icon
507
Tenaya Therapeutics
TNYA
$165M
$338K 0.05%
64,563
-16,692
-21% -$79.9K
ANNX icon
508
Annexon
ANNX
$883M
$335K 0.05%
46,698
OOMA icon
509
Ooma
OOMA
$593M
$328K 0.05%
38,472
-678
-2% -$6.75K
DIOD icon
510
Diodes
DIOD
$4.65B
$325K 0.05%
4,615
FATE icon
511
Fate Therapeutics
FATE
$322M
$322K 0.05%
43,812
+2,475
+6% +$15.3K
PYXS icon
512
Pyxis Oncology
PYXS
$243M
$319K 0.05%
74,903
BLDR icon
513
Builders FirstSource
BLDR
$7.74B
$318K 0.05%
1,524
CGEM icon
514
Cullinan Oncology
CGEM
$1.18B
$317K 0.05%
18,579
-139
-0.7% -$2.15K
PFG icon
515
Principal Financial Group
PFG
$24.4B
$305K 0.05%
3,535
GBIO
516
DELISTED
Generation Bio
GBIO
$302K 0.05%
7,417
+3,571
+93% +$84.1K
DECK icon
517
Deckers Outdoor
DECK
$13.3B
$301K 0.05%
1,920
GLUE icon
518
Monte Rosa Therapeutics
GLUE
$1.35B
$299K 0.05%
42,393
+14,549
+52% +$86.3K
VSTM icon
519
Verastem
VSTM
$615M
$298K 0.05%
25,274
CB icon
520
Chubb
CB
$134B
$292K 0.04%
1,126
-8,430
-88% -$2.07M
APD icon
521
Air Products & Chemicals
APD
$68.6B
$290K 0.04%
1,197
+438
+58% +$107K
ALLO icon
522
Allogene Therapeutics
ALLO
$725M
$287K 0.04%
64,103
+3,469
+6% +$14.5K
DIS icon
523
Walt Disney
DIS
$178B
$282K 0.04%
2,303
-91
-4% -$9.51K
FANG icon
524
Diamondback Energy
FANG
$55.7B
$274K 0.04%
1,382
-42
-3% -$7.13K
NRIX icon
525
Nurix Therapeutics
NRIX
$2.69B
$272K 0.04%
18,511

Similar funds

Cornercap Investment Counsel's Q1 2024 Portfolio in Review

As of Q1 2024, Cornercap Investment Counsel held 684 positions worth $649M, up 6.3% from $611M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Cornercap Investment Counsel's Q1 2024 filing shows 103 new, 174 increased, 151 reduced and 77 closed positions. Its largest new stake was Lockheed Martin: 4,734 shares worth $2.15M. The largest sale was CVS Health, an estimated $2.6M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Cornercap Investment Counsel's largest Q1 2024 buy was Lockheed Martin: 4,734 shares worth $2.15M.
  • Cornercap Investment Counsel added most to Applied Materials in Q1 2024, an estimated $2.43M increase.
  • Cornercap Investment Counsel's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.4M.
  • Cornercap Investment Counsel fully exited CVS Health in Q1 2024, selling an estimated $2.6M.
  • Cornercap Investment Counsel's ten largest holdings make up 8.4% of its $649M portfolio in Q1 2024.
  • Cornercap Investment Counsel opened 103 new positions and closed 77 in Q1 2024.
  • Cornercap Investment Counsel's portfolio value rose 6.3% quarter-over-quarter to $649M.

Based on Cornercap Investment Counsel's 13F filing for Q1 2024, filed 10 May 2024.